Home › Funds › EMERALD ADVISERS, LLC › PVLA

EMERALD ADVISERS, LLC position in PVLA

PALVELLA THERAPEUTICS INC NE · Health Care

EMERALD ADVISERS, LLC reported holding 229,404 shares of PVLA (PALVELLA THERAPEUTICS INC NE) in its Q3 2026 13F filing — a position valued at US$31.6M, representing 0.87% of its reported portfolio and ranking #48 among its reported holdings. EMERALD ADVISERS, LLC has disclosed PVLA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)229.40K sh
Reported value held$31.64M
Portfolio Weight0.87%
First reportedQ1 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EMERALD ADVISERS, LLC's PVLA position evolved

EMERALD ADVISERS, LLC first disclosed a stake in PVLA in Q1 2026 at 161,500 shares (US$20.1M). The position peaked in Q2 2026 at 229,486 shares, worth US$35.1M. Across 3 filings, EMERALD ADVISERS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 229,404 shares valued at US$31.6M. Notable position changes include a 42% increase in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 161.50K $20.13M New
Q2 2026 229.49K $35.07M Add
Q3 2026 229.40K $31.64M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NE) is a Health Care company. 83 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has EMERALD ADVISERS, LLC held PVLA?

EMERALD ADVISERS, LLC has disclosed PVLA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is EMERALD ADVISERS, LLC's current position in PVLA?

As of Q3 2026, EMERALD ADVISERS, LLC holds 229.40K shares of PVLA (PALVELLA THERAPEUTICS INC NE), valued at $31.64M, representing 0.87% of its reported portfolio and ranking #48.

Has EMERALD ADVISERS, LLC been buying or selling PVLA?

In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC held unchanged its position in PVLA. The position peaked in Q2 2026 at 229.49K shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 83 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.